DuPont Introduces High‑Performance FilmTec Fortilife Reverse‑Osmosis Elements XC‑Max UHP and XC‑220

DD
April 09, 2026

DuPont de Nemours, Inc. announced the launch of two new FilmTec Fortilife® reverse‑osmosis membrane elements, the XC‑Max UHP and XC‑220, designed to increase water recovery rates and improve the performance of Zero Liquid Discharge (ZLD) and Minimal Liquid Discharge (MLD) systems.

The XC‑220 element can concentrate brine to 220 g/L NaCl at operating pressures up to 83 bar, while the XC‑Max UHP can achieve reject TDS concentrations of 250 g/L NaCl at pressures up to 120 bar. These specifications enable higher recoveries and reduce the need for downstream treatment steps, allowing industrial customers to operate at higher salinities and pressures traditionally served by thermal processes.

The launch aligns with DuPont’s strategic focus on its Water Solutions business, which has become part of the Healthcare & Water Technologies segment after the separation of its Electronics division. By expanding its membrane portfolio, DuPont is positioning itself to help customers meet tightening discharge regulations and to improve water‑reuse efficiency in a market that is growing as water scarcity and environmental compliance pressures increase.

The new elements address a key industry trend toward sustainability and resource recovery. High‑salinity, high‑pressure reverse‑osmosis technology offers a more energy‑efficient alternative to conventional thermal methods, potentially capturing a niche segment of industrial customers seeking to reduce energy and chemical costs while meeting regulatory requirements.

The introduction of the XC‑Max UHP and XC‑220 underscores DuPont’s commitment to innovation in water treatment and reinforces its leadership position in the global water‑solutions market.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.